http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015230947-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0b331f92a455bc609caacfe7ba10edab
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-2476
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-82
filingDate 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f03e7ba9847a8835646ccd39500dc6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35efe6ea37c437a477d637f27715ca84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f03fd68c4f7195f6146194c5f88cd07b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b65f38ee1d9683eaddaa9d68e9b44b3b
publicationDate 2015-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2015230947-A1
titleOfInvention Tricuspid Regurgitation Model and Methods of Evaluating Intraluminal Medical Devices
abstract Animal models useful in the evaluation of medical devices, such as intraluminal medical devices, including intraluminal valve prostheses, are described. An example animal model comprises an animal in which a chordae tendineae attached to at least one of the leaflets of the tricuspid valve has been cut during an interventional procedure. Methods of evaluating intraluminal medical devices are also described. An example methods comprises cutting chordae tendineae attached to a leaflet of a tricuspid valve of an animal; allowing the animal to recover from the step of cutting the chordae tendineae; implanting an intraluminal medical device at a target site within a body vessel of the animal; allowing the animal to recover from the step of implanting an intraluminal medical device; and monitoring in vivo performance of the intraluminal medical device.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015257883-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10667804-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10390943-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9572666-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11653947-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10363138-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10426616-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10736632-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11071564-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11166818-B2
priorityDate 2014-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5595571-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8709076-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6355030-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395816
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9861403
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533737
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54678486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396699
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127712924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16204922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396698
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9796
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110

Total number of triples: 49.